127 related articles for article (PubMed ID: 8870416)
1. Serum levels of squamous cell carcinoma antigen and carcinoembryonic antigen as tumor markers of vulvar cancer.
Yamawaki T; Takeshima N; Shimizu Y; Teshima H; Hasumi K
J Obstet Gynaecol Res; 1996 Aug; 22(4):341-6. PubMed ID: 8870416
[TBL] [Abstract][Full Text] [Related]
2. [The clinical signifinace of CEA, Cyfra21-1 and SCC in laryngeal carcinoma's clinicopathological parameters].
Rao LH; Zhang L; Tian L; Yan JR; Xiang XY; Yu FB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Aug; 31(15):1182-1186. PubMed ID: 29798354
[No Abstract] [Full Text] [Related]
3. Predictive significance of CYFRA21-1, squamous cell carcinoma antigen and carcinoembryonic antigen for lymph node metastasis in patients with esophageal squamous cancer.
Mei X; Zhu X; Zuo L; Wu H; Guo M; Liu C
Int J Biol Markers; 2019 Jun; 34(2):200-204. PubMed ID: 31088185
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.
Bae SN; Namkoong SE; Jung JK; Kim CJ; Park JS; Kim JW; Lee JM; Kim SJ
Gynecol Oncol; 1997 Mar; 64(3):418-24. PubMed ID: 9062143
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of tumor markers for early detection of recurrence in patients with cervical adenocarcinoma and adenosquamous carcinoma.
Tabata T; Takeshima N; Tanaka N; Hirai Y; Hasumi K
Tumour Biol; 2000; 21(6):375-80. PubMed ID: 11006578
[TBL] [Abstract][Full Text] [Related]
6. Serum squamous cell carcinoma antigen levels in invasive squamous vulvar cancer.
Rose PG; Nelson BE; Fournier L; Hunter RE
J Surg Oncol; 1992 Jul; 50(3):183-6. PubMed ID: 1619942
[TBL] [Abstract][Full Text] [Related]
7. Significance of serum SCC antigen as a tumor marker in patients with squamous cell carcinoma of the vulva.
van der Sijde R; de Bruijn HW; Krans M; Bouma J; Aalders JG
Gynecol Oncol; 1989 Nov; 35(2):227-32. PubMed ID: 2807015
[TBL] [Abstract][Full Text] [Related]
8. Squamous cell carcinoma antigen serum levels as prognostic parameter in patients with early stage vulvar cancer.
Hefler LA; Sliutz G; Leodolter S; Speiser P; Joura E; Reinthaller A; Kohlberger P
Gynecol Oncol; 2005 Jun; 97(3):904-7. PubMed ID: 15894354
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of serum high-mobility group box 1 detection in esophageal squamous cell carcinoma].
Chen CG; Cui L; Tang P; Yu ZT
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):838-41. PubMed ID: 24061989
[TBL] [Abstract][Full Text] [Related]
10. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
[TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of squamous-cell carcinoma antigen and tissue polypeptide antigen in the follow-up of patients with vulvar cancer.
Hefler L; Frischmuth K; Heinze G; Sliutz G; Leodolter S; Reinthaller A; Kainz C; Tempfer C
Int J Cancer; 1999 Oct; 83(2):167-70. PubMed ID: 10471522
[TBL] [Abstract][Full Text] [Related]
12. Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus.
Kanda M; Koike M; Shimizu D; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Omae K; Yamada S; Nakayama G; Kodera Y
Ann Surg Oncol; 2020 Apr; 27(4):1233-1240. PubMed ID: 31650302
[TBL] [Abstract][Full Text] [Related]
13. Serum CEA, CA125, and SCC antigens and tumor recurrence in resectable non-small cell lung cancer.
Diez M; Gomez A; Hernando F; Ortega MD; Maestro ML; Torres A; Mugüerza JM; Gutierrez A; Granell J; Balibrea JL
Int J Biol Markers; 1995; 10(1):5-10. PubMed ID: 7629428
[TBL] [Abstract][Full Text] [Related]
14. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.
Ma Q; Liu W; Jia R; Jiang F; Duan H; Lin P; Zhang L; Long H; Zhao H; Ma G
World J Surg Oncol; 2016 May; 14():141. PubMed ID: 27151090
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of squamous cell carcinoma antigen as a predictor of inguinofemoral lymph node metastasis in patients with vulvar cancer.
Nather A; Sami A; Hefler L; Leodolter S; Joura EA
J Reprod Med; 2002 Sep; 47(9):718-20. PubMed ID: 12380452
[TBL] [Abstract][Full Text] [Related]
16. [The diagnostic value of the tumor markers CEA, "Ca 19-9", "Ca 125", "Ca15-3" and "SCC" for the detection of recurrent tumors in patients with tumors of the head and neck].
Zöller J; Fiehn W; Mende U; Hotz G
Dtsch Z Mund Kiefer Gesichtschir; 1990; 14(4):254-9. PubMed ID: 2134649
[TBL] [Abstract][Full Text] [Related]
17. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix.
Takeda M; Sakuragi N; Okamoto K; Todo Y; Minobe S; Nomura E; Negishi H; Oikawa M; Yamamoto R; Fujimoto S
Acta Obstet Gynecol Scand; 2002 May; 81(5):451-7. PubMed ID: 12027820
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of squamous cell carcinoma antigen in cancer of the human uterine cervix. Comparison with CEA and CA-125.
Verlooy H; Devos P; Janssens J; Mortelmans L; Gerits M; Bonte J; De Roo M
Gynecol Obstet Invest; 1991; 32(1):55-8. PubMed ID: 1765320
[TBL] [Abstract][Full Text] [Related]
19. The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix.
de Bruijn HW; Duk JM; van der Zee AG; Pras E; Willemse PH; Boonstra H; Hollema H; Mourits MJ; de Vries EG; Aalders JG
Tumour Biol; 1998; 19(6):505-16. PubMed ID: 9817980
[TBL] [Abstract][Full Text] [Related]
20. Experiences with SCC antigen, a new tumor marker for cervical carcinoma.
Meier W; Eiermann W; Stieber P; Schneider A; Fateh-Moghadam A; Hepp H
Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1555-9. PubMed ID: 2591447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
